Status: Recruiting
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
The purpose of this study is to find out whether SER-155 may be a safe first treatment that causes few or mild side effects for people due to irEC.
Participants needed: 15
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Dec 2, 2025Locations: 7
Eligibility criteria
Age > 18 years [+5]
Active GI infection, including untreated viral, bacterial or fungal cause(s) of... [+12]